BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9309138)

  • 1. [Tumor suppressive function of gelsolin].
    Kuzumaki N; Tanaka M; Sakai N; Fujita H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1436-41. PubMed ID: 9309138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gelsolin gene therapy by retrovirus producer cells for human bladder cancer in nude mice.
    Tanaka M; Sazawa A; Shinohara N; Kobayashi Y; Fujioka Y; Koyanagi T; Kuzumaki N
    Cancer Gene Ther; 1999; 6(5):482-7. PubMed ID: 10505859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of G2 checkpoint function by gelsolin transfection in human cancer cells.
    Sakai N; Ohtsu M; Fujita H; Koike T; Kuzumaki N
    Exp Cell Res; 1999 Aug; 251(1):224-33. PubMed ID: 10438588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelsolin: a candidate for suppressor of human bladder cancer.
    Tanaka M; Müllauer L; Ogiso Y; Fujita H; Moriya S; Furuuchi K; Harabayashi T; Shinohara N; Koyanagi T; Kuzumaki N
    Cancer Res; 1995 Aug; 55(15):3228-32. PubMed ID: 7614452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progress of research on tumor suppressor genes].
    Kuzumaki N
    Hokkaido Igaku Zasshi; 1996 Mar; 71(2):133-7. PubMed ID: 8641669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gelsolin gene therapy using adenovirus vector for orthotopically implanted human urinary bladder carcinoma in nude mice].
    Sazawa A
    Hokkaido Igaku Zasshi; 2001 Jul; 76(4):263-71. PubMed ID: 11523117
    [No Abstract]   [Full Text] [Related]  

  • 7. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers.
    Dosaka-Akita H; Hommura F; Fujita H; Kinoshita I; Nishi M; Morikawa T; Katoh H; Kawakami Y; Kuzumaki N
    Cancer Res; 1998 Jan; 58(2):322-7. PubMed ID: 9443412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of growth in vitro and tumorigenicity in vivo of human carcinoma cell lines by transfected p16INK4.
    Spillare EA; Okamoto A; Hagiwara K; Demetrick DJ; Serrano M; Beach D; Harris CC
    Mol Carcinog; 1996 May; 16(1):53-60. PubMed ID: 8634094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effect of bladder cancer related protein gene on HeLa cell proliferation].
    Zuo ZH; Zhao M; Liu J; Wei Y; Wu XX
    Ai Zheng; 2006 Jul; 25(7):811-7. PubMed ID: 16831269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
    Loskog A; Tötterman TH; Böhle A; Brandau S
    Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
    Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H; Lai B; Li J
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus mediated gelsolin gene therapy for orthotopic human bladder cancer in nude mice.
    Sazawa A; Watanabe T; Tanaka M; Haga K; Fujita H; Harabayashi T; Shinohara N; Koyanagi T; Kuzumaki N
    J Urol; 2002 Sep; 168(3):1182-7. PubMed ID: 12187264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.
    Inoue K; Slaton JW; Kim SJ; Perrotte P; Eve BY; Bar-Eli M; Radinsky R; Dinney CP
    Cancer Res; 2000 Apr; 60(8):2290-9. PubMed ID: 10786697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple inhibitory mechanisms of wild-type p16 gene transfer into human bladder cells by retroviral vector].
    Wu Y; Ma T; Wu H; Zhang W; Wu C
    Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):456-8. PubMed ID: 11829887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
    Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
    Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressive function of mutated gelsolin in ras-transformed cells.
    Müllauer L; Fujita H; Ishizaki A; Kuzumaki N
    Oncogene; 1993 Sep; 8(9):2531-6. PubMed ID: 8395682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
    Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
    Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.